Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-08-01
1997-01-28
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514885, 4241951, A61H 31705, A61K 3578
Patent
active
055978070
ABSTRACT:
Novel Quinoa saponin pharmaceutical compositions are disclosed. The compositions are useful as immunological adjuvants, to stimulate nonspecific immunity, as well as to enhance an immunological response to a selected antigen. The Quinoa saponin compositions can also be used to enhance mucosal absorption of a drug administered therewith.
REFERENCES:
patent: 4501734 (1985-02-01), Tanaka et al.
patent: 4806350 (1989-02-01), Gerber
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5118671 (1992-06-01), Bombardelli et al.
patent: 5147859 (1992-09-01), Bombardelli et al.
patent: 5290557 (1994-03-01), Mason et al.
Chem. Abstr. 112: 175533; 1990.
Bomford et al., "Adjuvanticity and ISCOM formation by structurally diverse saponins," Vaccine (1992) 10:572-577.
Estrada Alberto
Laarveld Bernard
Redmond Mark J.
Rollins John W.
University of Saskatchewan
LandOfFree
Quinoa saponin compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoa saponin compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoa saponin compositions and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941562